We recently compiled a list of the 10 Worst Performing Software Stocks to Buy According to Analysts. In this article, we are going to take a look at where Vertex, Inc. (NASDAQ:VERX) stands against the ...

Vertex (NASDAQ:VERX – Free Report) had its target price trimmed by Jefferies Financial Group from $62.00 to $48.00 in a ...

Google Cloud is enhancing its Vertex AI search platform for healthcare with multimodal AI capabilities. Specifically, it will ...

Stifel Nicolaus downgraded shares of Vertex (NASDAQ:VERX – Free Report) from a buy rating to a hold rating in a report ...

The stock's rise snapped a four-day losing streak.

Vertex, Inc. (VERX) has disclosed a new risk, in the Debt & Financing category. Vertex, Inc. faces significant financial risk in the event of a ...

Google Cloud today announced new generative AI (gen AI) capabilities in Vertex AI Search for healthcare, including a new feature called Visual Q&A that searches tables, charts, and diagrams, and the ...

Vertex has backed out of its in vivo gene editing collaboration with Verve Therapeuti | Vertex has backed out of its in vivo ...

BMO Capital analyst Daniel Jester lowered the firm’s price target on Vertex (VERX) to $41 from $56 and keeps a Market Perform rating on the shares. The firm had previously indicated that shares had ...

The companies were two years into a four-year, $400 million agreement aimed at developing and marketing gene therapies ...

DA Davidson analyst William Jellison lowered the firm’s price target on Vertex (VERX) to $55 from $62 and keeps a Buy rating on the shares.

Verve offered few details on the early end of a collaboration the companies inked in 2022, saying only that Vertex cited “changing priorities.” ...